PFO
NVRO

Pathstone Family Office’s NEVRO CORP. NVRO Stock Holding History

Pathstone Family Office’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-70
Closed -$12K – 1380
2020
Q4 		$12K Hold
70
– – ﹤0.01% 851
2020
Q3 		$10K Buy
70
+45
+180% +$6.01K ﹤0.01% 603
2020
Q2 		$3K Buy
+25
New +$2.96K ﹤0.01% 611

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pathstone Family Office's NVRO Position: Q1 2021 in Review

Pathstone Family Office sold out of NEVRO CORP. (NVRO) in Q1 2021, closing a stake of 70 shares — an estimated $12K sold.

Pathstone Family Office first reported a position in NVRO in Q2 2020 and held it in 3 quarters. The position peaked at $12K in Q4 2020. 204 funds tracked by Wall St. Rank hold NVRO as of Q1 2021.

  • Pathstone Family Office reported no remaining NEVRO CORP. position as of Q1 2021 after selling out during the quarter.
  • Pathstone Family Office sold 70 NEVRO CORP. shares in Q1 2021, an estimated $12K.
  • Pathstone Family Office first reported a position in NEVRO CORP. in Q2 2020 and held it in 3 quarters.
  • Pathstone Family Office's NEVRO CORP. position peaked at $12K in Q4 2020.
  • 204 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.